The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

University of Washington ACTU Seeks Participants for Two New Studies

Spring 2003

University of Washington
AIDS Clinical Trials Unit
325 9th Avenue, Second Floor (2West Clinic)
Seattle, WA 98104

Latest HIV/AIDS Clinical Trials

Neuropathy Study

Open-label, Dose-escalation, Dideoxynucleoside-Associated Distal Symmetric Peripheral Neuropathy Pilot Study

Purpose: to see if taking acetyl-L-carnitine (ALC), an investigational substance, reduces neuropathy (numbness, pain, or tingling in legs and feet) in people who are taking anti-HIV drugs ddC, or ddI or d4T.

Length: 24 weeks

Reimbursement: exams, acetyl-L-carnitine, and lab tests given at no cost. Reimbursement of $20 per visit plus $50 for each visit when skin biopsies are done.

Contact: Alyssa Spingola or Lori Cray at (206) 731-3184 (

Semen Study

Crossover trial of valganciclovir in persons with HIV-1 infection and HIV and CMV co-shedding in semen

Purpose: to evaluate the effectiveness of oral valganciclovir in decreasing the shedding of HIV in semen.

Length: 12 weeks after entry

Reimbursement: Semen samples are reimbursed at the following rates: $15 for screening samples, $25 for each of the three samples at weeks 2-4, and $40 for each of the samples at weeks 8, 10, 11, and 12.

Contact: Leslie Deutsch (206) 543-8299 (

  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Perspective.
See Also